Literature DB >> 36153465

The relationship between perianal fistula activity and abdominal adipose tissue in Crohn's disease: an observational study.

Ziman Xiong1, Ziling Zhou1,2, Luwen Hao1, Yuanqiu Li1, Xuemei Hu1, Daoyu Hu1, Yan Luo1, Yanchun Wang1, Yaqi Shen3, Zhen Li1.   

Abstract

OBJECTIVE: The aim of this study was to analyze the relationship between abdominal adipose tissue and perianal fistula activity in patients with Crohn's disease (CD) using cross-sectional imaging.
METHODS: Patients with perianal fistulizing CD who underwent pelvic magnetic resonance imaging (MRI) and abdominal computed tomography (CT) were retrospectively enrolled. We scored the fistulas in each patient's MRI images based on Van Assche's classification. The area and density of subcutaneous adipose tissue (SAT) and visceral adipose tissue (VAT) (at the third, fourth, and fifth lumbar (L3, L4, and L5) levels were measured by averaging five slices of measurements at each vertebral level in CT images, and areas were further standardized by the lumbar height2 (heightL1-5). The VAT/SAT ratio (VSR) and VAT/Total adipose tissue (VA/TA) index were calculated. Based on MRI scores, patients were divided into two groups with low and high activity, and their clinical, MRI features, and CT parameters were compared. We evaluated patients with follow-up MRI and compared the differences in clinical and radiological indicators among patients with different outcomes.
RESULTS: Overall, 136 patients were included, 77 in the low-activity group and 59 in the high-activity group. Patients in the high activity group had lower subcutaneous adipose index (all levels, p < 0.05) and visceral adipose index (L3 level, p < 0.01), but higher SAT and VAT density (all levels, p < 0.01), VSR (L5 level, p = 0.07) and VA/TA index (L5 level, p < 0.05).
CONCLUSION: There were differences in adipose tissue composition among CD patients with different active perianal fistulas.
© 2022. The Author(s).

Entities:  

Keywords:  Crohn's disease; Magnetic resonance imaging; Perianal fistula; Tomography (X-ray computed); Visceral adipose tissue

Year:  2022        PMID: 36153465      PMCID: PMC9509502          DOI: 10.1186/s13244-022-01293-6

Source DB:  PubMed          Journal:  Insights Imaging        ISSN: 1869-4101


  38 in total

1.  The natural history of fistulizing Crohn's disease in Olmsted County, Minnesota.

Authors:  David A Schwartz; Edward V Loftus; William J Tremaine; Remo Panaccione; W Scott Harmsen; Alan R Zinsmeister; William J Sandborn
Journal:  Gastroenterology       Date:  2002-04       Impact factor: 22.682

2.  Visceral adiposity predicts post-operative Crohn's disease recurrence.

Authors:  D Q Holt; G T Moore; B J G Strauss; A L Hamilton; P De Cruz; M A Kamm
Journal:  Aliment Pharmacol Ther       Date:  2017-02-28       Impact factor: 8.171

3.  Evaluation of an MRI-based score of disease activity in perianal fistulizing Crohn's disease.

Authors:  Karin Horsthuis; Manon L W Ziech; Shandra Bipat; Anje M Spijkerboer; Annette C de Bruine-Dobben; Daniel W Hommes; Jaap Stoker
Journal:  Clin Imaging       Date:  2011 Sep-Oct       Impact factor: 1.605

4.  Magnetic resonance imaging of the effects of infliximab on perianal fistulizing Crohn's disease.

Authors:  Gert Van Assche; Dirk Vanbeckevoort; Didier Bielen; Georges Coremans; Isolde Aerden; Maya Noman; Andre D'Hoore; Freddy Penninckx; Guy Marchal; Freddy Cornillie; Paul Rutgeerts
Journal:  Am J Gastroenterol       Date:  2003-02       Impact factor: 10.864

5.  Anal pathology in patients with Crohn's disease.

Authors:  C Platell; J Mackay; B Collopy; R Fink; P Ryan; R Woods
Journal:  Aust N Z J Surg       Date:  1996-01

6.  Prospective assessment of the effect on quality of life of anti-tumour necrosis factor therapy for perineal Crohn's fistulas.

Authors:  S C Ng; S Plamondon; A Gupta; D Burling; M A Kamm
Journal:  Aliment Pharmacol Ther       Date:  2009-07-03       Impact factor: 8.171

7.  Visceral Adipose Tissue in Patients with Crohn's Disease Correlates with Disease Activity, Inflammatory Markers, and Outcome.

Authors:  Carsten Büning; Christian von Kraft; Mario Hermsdorf; Enno Gentz; Eva K Wirth; Luzia Valentini; Verena Haas
Journal:  Inflamm Bowel Dis       Date:  2015-11       Impact factor: 5.325

8.  Anal fistulas in Crohn's disease: incidence and outcome of surgical treatment.

Authors:  S Nordgren; S Fasth; L Hultén
Journal:  Int J Colorectal Dis       Date:  1992-12       Impact factor: 2.571

9.  Usual therapy improves perianal Crohn's disease as measured by a new disease activity index. McMaster IBD Study Group.

Authors:  E J Irvine
Journal:  J Clin Gastroenterol       Date:  1995-01       Impact factor: 3.062

10.  Modified Van Assche magnetic resonance imaging-based score for assessing the clinical status of anal fistulas.

Authors:  Wei-Guo Wang; Wen-Zhu Lu; Chun-Mei Yang; Ke-Qiang Yu; Hong-Bo He
Journal:  Medicine (Baltimore)       Date:  2020-05       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.